Skip to main content

Table 6 AEs reported in >1 subject with normal renal function and varying degrees of renal impairment

From: Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies

  

Degree of renal impairment

Adverse event, n (%)

Normal renal function (n = 18)

Mild (n = 12)

Moderate (n = 9)

Severe (n = 9)

Any AE

14 (78)

7 (58)

8 (89)

7 (78)

Headache

14 (78)

6 (50)

5 (56)

4 (44)

Nasopharyngitis

1 (6)

1 (8)

2 (22)

0

Fatigue

0

1 (8)

1 (11)

2 (22)

Somnolence

2 (11)

1 (8)

0

0

Nausea

1 (6)

1 (8)

0

1 (11)

Neck pain

0

2 (17)

0

0

Back pain

1 (6)

1 (8)

0

0

Dizziness

0

0

2 (22)

0

Dyspepsia

1 (6)

0

0

1 (11)